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Supplementary Figure 1 | CL-316243 stimulation downregulates miR-327 in WAT-SVF 5 
(a) qPCR analysis of miR-327 in visWAT-SVFs of 1-, 3- and 7-day CL-316243- treated 6 
C57BL/6 mice compared to vehicle treated controls. Sno-202 served as internal control (n = 5 7 
samples per group).  8 
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Supplementary Figure 2 | Fgf10 mRNA is predominantly expressed by non-adipocytes in 3 
WAT. (a) qPCR analysis of WAT-SVFs compared to the WAT-adipocyte fractions isolated 4 
from C57BL/6 mice. Actb served as an internal control (n = 5 samples per group). n.s., not 5 
significant. *P<0.05, **P<0.01, and ***P<0.001 by Student’s t-test. Data presented as mean ± 6 
s.e.m. 7 
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Supplementary Figure 3 | Effects of browning and miR-327 alterations on miR-327, Fgf10 1 
and Fgfr2 RNA levels, browning factors and FGF10 protein levels. (a-d) qPCR analysis of 2 
miR-327, Fgf10 and Fgfr2 in primary white adipocytes (WAC) and brown adipocytes (BAC) 3 
derived from scWAT, visWAT and iBAT from 1-week-4 °C-exposed C57BL/6 mice relative 4 
to the 30 °C control group. Sno-202 or Actb served as internal controls (n = 5 samples per 5 
group). (e) qPCR analysis of miR-327 levels in 3T3-L1 preadipocytes treated with miR-327 6 
mimics or inhibitors compared to respective controls. Sno-202 served as internal control (n = 5 7 
samples per group). (f-i) qPCR analysis of Ucp1, Cidea, Ppargc1a, and Cox7a in 8 
undifferentiated (UD), 2-day differentiated (2-day diff.) and 6-day differentiated (6-day diff.) 9 
3T3-L1 cells treated with miR-NC, miR-NC plus isoproterenol (miR-NC + Isop) for 4h, miR-10 
327, and miR-327 plus isoproterenol (miR-NC + Isop.). mRNA levels were normalized to the 11 
miR-NC group and Actb served as an internal control (n = 5 samples per group). (j, k) ELISA 12 
analysis of extracellular and intracellular FGF10 protein levels in 3T3-L1 preadipocytes and 13 
differentiated adipocytes receiving non-treatment (NT) or treatment prior to differentiation with 14 
miR-NC, miR-327, Inh-miR-327, Scramble, or siFGF10. Extracellular FGF10 concentrations 15 
were determined using 72 h-conditioned medium (n = 5 samples per group). n.s., not significant. 16 
*P<0.05, **P<0.01, and ***P<0.001 by Student’s t-test. Data presented as mean ± s.e.m. 17 
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Supplementary Figure 4 | Proliferation of preadipocytes under various treatment 3 
conditions. (a-c) Proliferation of undifferentiated (UD), 2-day differentiated (2-day diff.) and 4 
6-day differentiated (6-day diff.) 3T3-L1 cells receiving recombinant FGF10, siFgf10, miR-5 
327 mimic or miR327 inhibitor treatment. Proliferating cells were normalized to the non-treated 6 
(NT) controls (n = 8 samples per group). (d-g) Immunohistochemical analysis and 7 
quantification of Ki67+ proliferating cells. DAPI was used to stain cell nuclei. Arrows point to 8 
proliferating cells, Scale bar, 100 µm, >30 adipocytes per field; n = 10 random fields. n.s., not 9 
significant. *P<0.05, **P<0.01, and ***P<0.001 by Student’s t-test. Data presented as mean ± 10 
s.e.m. 11 
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Supplementary Figure 5 | Ad-miR-327 inhibits WAT browning. (a) Histological analysis 1 
of GFP+ cells in visWAT transfected with a control adenovirus (Ad-miR-NC) or an adenovirus 2 
expressing miR-327 (Ad-miR-327). Perilipin (PERI) was used to identify adipose tissues. 3 
Arrows point to GFP+ cells. (b) qPCR analysis of miR-327 expression in Ad-miR-327 4 
compared to Ad-miR-NC. Sno-202 served as internal control (n = 6 samples per group). (c, g) 5 
Histological analysis of adipocyte morphology (H&E), adipocytes (PERI), mitochondria 6 
(COX4) and uncoupling protein (UCP1) in (c) 5-day CL-316243 treated visWAT compared to 7 
vehicle treated control. (g) 2-week 4 °C treated visWAT compared to 30 °C control. Double-8 
headed arrows mark adipocyte diameter. Arrows point to respective positive signals. (d-f and 9 
h-j) Quantifications of adipocyte size and positive signals of COX4 and UCP1 in (d-f) CL-10 
316243- and vehicle-, and (h-j) 30 °C- and 4 °C- treated visWATs (>30 adipocytes per field; n 11 
= 10 random fields; n =6 mice per group). Immunodeficient NSG mice were used for all 12 
experiments in this figure. Scale bars, 100 μm. n.s., not significant. **P<0.01, and ***P<0.001 13 
by Student’s t-test. Data presented as mean ± s.e.m. 14 
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Supplementary Figure 6 | Global metabolic changes of miR-327-treated mice (a-h) Body 3 
weight, food intake, visWAT weight, and iBAT weight of NSG mice treated with Ad-miR-NC 4 
or Ad-miR-327, followed by 5-day CL-316243 treatment or 2-week 4 °C exposure (n = 12 mice 5 
per group). (i) Glucose tolerance test (GTT) of Ad-miR-NC- or Ad-miR-327-treated NSG mice 6 
under 2-week 30 °C or 4 °C exposure (n = 6-8 mice per group). (j) Homeostatic model 7 
assessment of insulin resistance (HOMA-IR) of Ad-miR-NC- or Ad-miR-327-treated NSG 8 
mice exposed for under 2-week 30 °C or 4 °C exposure (n = 6 mice per group). (k) Core body 9 
temperature of Ad-miR-NC- or Ad-miR-327-treated NSG mice under 2-week 30 °C or 4 °C 10 
exposure (n = 12 mice per group). n.s., not significant. *P<0.05, **P<0.01, and ***P<0.001 by 11 
Student’s t-test. Data presented as mean ± s.e.m. 12 
  13 
 9 
 1 
  2 
 10 
Supplementary Figure 7 | Inhibition of miR-327 does not affect BAT. (a) Histological 1 
analysis of adipocyte morphology (H&E), adipocytes (PERI), mitochondria (COX4) and 2 
uncoupling protein 1 (UCP1) in Inh-miR-NC- and Inh-miR-327-treated iBAT under 2-week 30 3 
°C or 4 °C exposure. Double-headed arrows mark adipocyte diameters. Arrows point to 4 
respective positive signals. (b-d) Quantifications of adipocyte size and positive signals of 5 
COX4 and UCP1 in Inh-miR-NC- and Inh-miR-327-treated iBAT under 2-week 30 °C or 4 °C 6 
exposure (>30 adipocytes per field; n = 10 random fields; n = 4 mice per group). (e-g) Western 7 
immunoblot analysis and quantification of FGF10 and UCP1 in Inh-miR-NC- and Inh-miR-8 
327-treated iBAT under 2-week 30 °C or 4 °C exposure. FGF10 and UCP1 protein levels were 9 
quantified as densitometric signals and normalized to β-Actin (n = 4 samples per group). Scale 10 
bars, 100 μm. kDa, kilodalton. n.s., not significant. *P<0.05, **P<0.01, and ***P<0.001 by 11 
Student’s t-test. Data presented as mean ± s.e.m.   12 
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Supplementary Figure 8 | Global metabolic changes of miR-327 inhibitor-treated mice. 2 
(a-d) Body weight, food intake, visWAT weight, and iBAT weight of C57BL/6 mice treated 3 
with Inh-miR-NC or Inh-miR-327, followed by 2-week 4 °C or 30 °C exposure (n = 12 mice 4 
per group). (e) Glucose tolerance test (GTT) of Inh-miR-NC- or Inh-miR-327-treated C57BL/6 5 
mice under 2-week 30 °C or 4 °C exposure (n = 6-8 mice per group). (f) Homeostatic model 6 
assessment of insulin resistance (HOMA-IR) of Inh-miR-NC- or Inh-miR-327-treated mice 7 
under 2-week 30 °C or 4 °C exposure (n = 6 mice per group). (g) Core body temperature of Inh-8 
miR-NC- or Inh-miR-327-treated mice under 2-week 30 °C or 4 °C exposure (n = 12 mice per 9 
group). n.s., not significant. *P<0.05, **P<0.01, and ***P<0.001 by Student’s t-test. Data 10 
presented as mean ± s.e.m. 11 
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Supplementary Figure 9 | Attenuation of miR-327 inhibition-triggered global metabolic 1 
phenotype in Fgf10+/- mice. (a) Western immunoblot analysis of FGF10 in scWAT, visWAT 2 
and iBAT of Fgf10+/- mice compared to those of WT mice. (b) Histological analysis of 3 
adipocyte morphology (H&E), adipocytes (PERI) and uncoupling protein 1 (UCP1) in iBAT 4 
isolated from Inh-miR-NC- and Inh-miR-327-treated 2-week-30 °C- exposed Fgf10+/- mice. 5 
Double-headed arrows mark adipocyte diameters. Arrows point to respective positive signals. 6 
(c-d) Quantifications of adipocyte size and positive signals of UCP1 in Inh-miR-NC- and Inh-7 
miR-327-treated 2-week 30 °C-exposed iBAT derived from Fgf10+/- mice (>30 adipocytes per 8 
field; n = 10 random fields). (e-h) Western immunoblot analysis and quantification of FGF10 9 
and UCP1 proteins in Inh-miR-NC- and Inh-miR-327-treated Fgf10+/- iBAT under 2-week 30 10 
°C exposure. FGF10 and UCP1 protein levels were quantified as densitometric signals and 11 
normalized to β-Actin (n = 5 samples per group). (i-n) Body weight, food intake, visWAT 12 
weight, iBAT weight, HOMA-IR, and core body temperature of Fgf10+/- mice treated with Inh-13 
miR-NC or Inh-miR-327 under 2-week 30 °C or 4 °C exposure (n = 5-8 samples per group). 14 
Scale bars, 100 μm. kDa, kilodalton. n.s., not significant. *P<0.05, **P<0.01, and ***P<0.001 15 
by Student’s t-test. Data presented as mean ± s.e.m. 16 
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Supplementary Figure 10 | Full gel scans for Fig 3a, 3b and 3c. (a) Gel scan for Fig. 3a. (b) 2 
Gel scan for Fig. 3b. (c) Gel scan for Fig. 3c. 3 
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Supplementary Figure 11 | Full gel scans for Fig 4b, 4e, 4g, 4i and 4k (a) Gel scan for Fig. 2 
4b. (b) Gel scan for Fig. 4e. (c) Gel scan for Fig. 4g. (d) Gel scan for Fig. 4i. (e) Gel scan for 3 
Fig. 4k. 4 
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Supplementary Figure 12 | Full gel scans for Fig 8a, 8b and 8c (a) Gel scan for Fig. 8a. (b) 2 
Gel scan for Fig. 8b. (c) Gel scan for Fig. 8c.   3 
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Supplementary Figure 13 | Full gel scans for Fig 9e and 9f (a) Gel scan for Fig. 9e. (b) Gel 2 
scan for Fig. 9f.  3 
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Supplementary Figure 14 | Full gel scans for Fig 10e and 10f (a) Gel scan for Fig. 10e. (b) 2 
Gel scan for Fig. 10f.  3 
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Supplementary Table 1 | Primer sequences 1 
  2 
Gene Forward primer sequence Reverse primer sequence
qPCR primers
Fgf10 5’-CCGACACCACCAGTTCCTAC-3’ 5’-CTTTGACGGCAACAACTCCG-3’
Actin 5’-AGGCCCAGAGCAAGAGAGG-3’ 5’-TACATGGCTGGGGTGTTGAA-3’
Pparg 5’-GTGCCAGTTTCGATCCGTAGA-3’ 5’-GGCCAGCATCGTGTAGATGA-3’
Prdm16 5’-CAGCACGGTGAAGCCATTC-3’ 5’-GCGTGCATCCGCTTGTG-3’
Ppargc1a 5’-AGCCGTGACCACTGACAACGAG-3’ 5’-GCTGCATGGTTCTGAGTGCTAAG-3’
Adipoq 5’-CTTTCATGTACACCGTGATGTG-3’ 5’-ACCTCTCCTGTTCCTCTTAATCC-3’
Cebpa 5’-TGGAGACGCAACAGAAGGTG-3’ 5’-CAGCCTAGAGATCCAGCGAC-3’
Cebpb 5’-GGGGTTGTTGATGTTTTTGGT-3’ 5’-TCGAAACGGAAAAGGTTCTCA-3’
Cebpg 5’-AATTGGCCCCAAAGAGCCTG-3’ 5’-CCCTACACTGGGATGCAGTT-3’
Ucp1 5’-AAACAGAAGGATTGCCGAAA-3’ 5’-TGCATTCTGACCTTCACGAC-3’
Cidea 5’-TGCTCTTCTGTATCGCCCAGT-3’ 5’-GCCGTGTTAAGGAATCTGCTG-3’
Cox7a 5’-CAGCGTCATGGTCAGTCTGT-3’ 5’-AGAAAACCGTGTGGCAGAGA-3’
Cox8b 5’-GAACCATGAAGCCAACGACT-3’ 5’-GCGAAGTTCACAGTGGTTCC-3’
Fgfr2 5’-CACTCGGGGATAAATAGCTCCAAT-3’ 5’-GCCAAAGTCTGCTATCTTCATCAC-3’
PCR primers for cloning
Fgf10 3'UTR bs1 5’-TCCTCCCCATGACGATCCAA-3’ 5’-ATGACCCAAGTGCTTTCCAGT-3’
Fgf10 3'UTR bs2 5’-TGGACCACCCACAACCAAAA-3’ 5’-CAGGGGGAAATGTAGGGTGG-3’
Mutated Fgf10 3'UTR bs1 5’-TCAAGTTTGGATGGAAGTTATCACG
ATGCGAACAATGTTGTGGTGGGGGC-3’
5’-GCCCCCACCACAACATTGTTCGCAT
CGTGATAACTTCCATCCAAACTTGA-3’
Mutated Fgf10 3'UTR bs2 5’-CTATGTGTAAACAGTCATCACGATAGT
ACTGCGGACATTAAACAGCTTCTAGCA-3’
5’-TGCTAGAAGCTGTTTAATGTCCGCAGT
ACTATCGTGATGACTGTTTACACATAG-3’
